Pamela Misajon serves as Executive at Kiromic Biopharma, Inc., where they oversee executive responsibilities. Since joining the company, Pamela Misajon has executed 4 insider transactions totaling $10.3K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jun 12, 2024 involved purchasing 410 shares valued at $1.3K.
Pamela Misajon currently holds 28,811 shares of Kiromic Biopharma, Inc. (KRBP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Pamela Misajon has been a net buyer of KRBP stock. They have purchased $10.3K and sold $0 worth of shares.
Pamela Misajon's most recent insider trade was on Jun 12, 2024, when they purchased 410 shares at $3.24 per share.
Get notified when new Form 4 filings are submitted
| $3.30 |
| Discretionary |
| Jun 10, 2024 | KRBP | $5.0K | Purchase | 1,701 | $2.93 | Discretionary |
| Mar 18, 2024 | KRBP | $0 | Award | 18,000 | $N/A | Discretionary |